Utilized UV, Inc. (NasdaqCM: AUVI) (“Utilized UV” or the “Firm”), a pathogen elimination expertise firm that applies the facility of narrow-range ultraviolet gentle (“UVC”) for floor areas and catalytic bioconversion expertise for air purification to destroy pathogens safely, completely, and routinely, at present introduced its Board of Administrators has licensed the money dividend to holders of Utilized UV’s 10.5% Collection A Cumulative Perpetual Most well-liked Inventory.
Holders of the ten.5% Collection A Cumulative Perpetual Most well-liked Inventory (Nasdaq: AUVIP) shall obtain a money dividend equal to $0.21875 per share.
The return of capital will probably be paid on or about Might 16, 2022, to respective holders of report on the shut of enterprise on Might 4, 2022.
About Utilized UV
Utilized UV is concentrated on the event and acquisition of expertise that tackle an infection management within the healthcare, hospitality, business and municipal markets. The Firm has two wholly owned subsidiaries – SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC (“Munn Works”). SteriLumen’s linked platform for Information Pushed Disinfection(TM) applies the facility of ultraviolet gentle (UVC) to destroy pathogens safely, completely, and routinely, addressing the problem of healthcare-acquired infections (“HAIs”). Focused to be used in amenities which have excessive buyer turnover equivalent to hospitals, motels, business amenities, and different public areas, the Firm’s Lumicide(TM) platform makes use of UVC LEDs in a number of patented designs for an infection management in and round high-traffic areas, together with sinks and restrooms, killing micro organism, viruses, and different pathogens residing on onerous surfaces inside units’ proximity. The Firm’s patented in-drain disinfection gadget, Lumicide Drain, is the one product in the marketplace that addresses this crucial pathogen intensive location. SteriLumen’s Airocide(TM) air purification units are analysis backed, clinically confirmed and developed for NASA with help from the College of Wisconsin. Airocide(TM) is listed as an FDA Class II Medical gadget, makes use of a proprietary photocatalytic (PCO) bioconversion expertise that attracts air right into a response chamber that converts damaging molds, microorganisms, harmful airborne pathogens, harmful VOCs, allergens, odors and organic gasses into innocent water vapor and inexperienced carbon dioxide with out producing ozone or different dangerous byproducts. Airocide(TM) purposes embody healthcare, hospitality, grocery chains, wine making amenities, business actual property, faculties, dental places of work, post-harvest, grocery, hashish amenities and houses. For extra details about Utilized UV, Inc., and its subsidiaries, please go to the next web sites: https://www.applieduvinc.com/; https://sterilumen.com/; https://www.airocide.com; https://kesscience.com; https://scientificairmanagement.com and, https://munnworks.com/.
Ahead-Wanting Statements
The knowledge contained herein could include “forward-looking statements.” Ahead-looking statements replicate the present view about future occasions. When used on this press launch, the phrases “anticipate,” “consider,” “estimate,” “anticipate,” “future,” “intend,” “plan,” or the detrimental of those phrases and comparable expressions, as they relate to us or our administration, establish forward-looking statements. Such statements embody, however usually are not restricted to, statements contained on this press launch referring to the view of administration of Utilized UV regarding its enterprise technique, future working outcomes and liquidity and capital sources outlook. Ahead-looking statements are based mostly on the Firm’s present expectations and assumptions relating to its enterprise, the economic system and different future circumstances. As a result of forward-looking statements relate to the long run, they’re topic to inherent uncertainties, dangers and modifications in circumstances which can be troublesome to foretell. The Firm’s precise outcomes could differ materially from these contemplated by the forward-looking statements. They’re neither statements of historic truth nor ensures of assurance of future efficiency. We warning you subsequently in opposition to counting on any of those forward-looking statements. Elements or occasions that would trigger the Firm’s precise outcomes to vary could emerge occasionally, and it’s not doable for the Firm to foretell all of them. The Firm can not assure future outcomes, ranges of exercise, efficiency, or achievements. Besides as required by relevant regulation, together with the securities legal guidelines of america, the Firm doesn’t intend to replace any of the forward-looking statements to evolve these statements to precise outcomes.
